Financing ·
Cardiol Therapeutics establishes US$75M at-the-market equity offering program with Jefferies
CRDLCardiol Therapeutics Inc.
Cardiol Therapeutics Inc. entered into an Open Market Sale Agreement with Jefferies LLC to sell common shares having an aggregate offering price of up to US$75,000,000. The agreement allows the company to issue and sell shares from time to time through Jefferies acting as sales agent or directly to Jefferies as principal. Sales will be conducted via at-the-market distributions on NASDAQ or other existing trading markets in the United States. The program is subject to terms including a minimum floor price of US$1.00 per share and a selling commission of up to 3.0% of gross proceeds. Cardiol Therapeutics Inc. operates in the biotechnology sector, focusing on the development of novel therapies for cardiovascular diseases.